
MENARINI SILICON BIOSYSTEMS SPA
MENARINI SILICON BIOSYSTEMS SPA
2 Projects, page 1 of 1
Open Access Mandate for Publications assignment_turned_in Project2020 - 2023Partners:UCC, MENARINI SILICON BIOSYSTEMS SPA, B. Braun (Germany), BSL, TUW +63 partnersUCC,MENARINI SILICON BIOSYSTEMS SPA,B. Braun (Germany),BSL,TUW,PHILIPS ELECTRONICS NEDERLAND B.V.,ANSEM,University of Turku,GAUDLITZ GMBH,INPHER SARL,MICRONIT BV,MicroLIQUID (Spain),HI Iberia (Spain),UNIPV,MCS,HUN-REN CENTRE FOR ENERGY RESEARCH,EMFIT,BESI,STMicroelectronics (Switzerland),Okmetic,IMEC-NL,PRECORDIOR OY,OSYPKA,CSEM,INSTITUTUL NATIONAL DE CERCETAREDEZVOLTARE PENTRU MICROTEHNOLOGIE,University of Florence,INESC ID,OY EVERON AB,PICOSUN OY,Salvia BioElectronics,TU Delft,INESC MICROSISTEMAS E NANOTECNOLGIAS-INSTITUTO DE,AbbVie Ireland NL B.V.,TU/e,REMOTEA OY,IRBLEIDA,EVG,THALES DIS FINLAND OY,SILICONGATE LDA,3db,www.gobiond.com,Microfluidic ChipShop (Germany),KIT,Micronit Microfluidics (Netherlands),University of Freiburg,UM,IHS WEIGLING SOCIEDAD LIMITADA,BEONCHIP SL,UPV/EHU,DYB DYCONEX SA DYCONEX LTD,Integer,TEKNOLOGIAN TUTKIMUSKESKUS VTT OY,PDM&FC,University of Zaragoza,INL,AESCULAP AG,INSPHERO,FHG,ICSENSE,IMEC,CORTEC,AEDUS SPACE KORLATOLT FELELOSSEGU TARSASAG,Roma Tre University,Besi Netherlands BV,IT,FUNDACION INSTITUTO DE INVESTIGACION SANITARIA ARAGON,TNO,PHILIPS MEDICAL SYSTEMS NEDERLANDFunder: European Commission Project Code: 876190Overall Budget: 65,224,200 EURFunder Contribution: 16,869,800 EURCompared to the pace of innovation in electronic consumer products, the pace of innovation for medical devices is lagging behind. It is the overarching objective of Moore4Medical to accelerate innovation in electronic medical devices. Moore4Medical emerging medical applications that offer significant new opportunities for the ECS industry including: active implantable devices (bioelectronic medicines), organ-on-chip, drug adherence monitoring, smart ultrasound, radiation free interventions and continuous monitoring. The new technologies will help fighting the increasing cost of healthcare by: reducing the need for hospitalization, helping the development of personalized therapies, and realizing intelligent point-of-care diagnostic tools. Moore4Medical will bring together 68 specialists from 12 countries who will develop open technology platforms for these emerging fields to help them bridge “the Valley of Death” in shorter time and at lower cost. Open technology platforms used by multiple users for multiple applications with the prospect of medium to high volume markets are an attractive proposition for the European ECS industry. The combination of typical MedTech applications with an ECS style platform approach will enhance the competitiveness for the emerging medical domains addressed in Moore4Medical. With value and IP moving from the technology level towards applications and solutions, defragmentation and open technology platforms will be key in acquiring and maintaining a premier position for Europe in the forefront of affordable healthcare
more_vert Open Access Mandate for Publications assignment_turned_in Project2015 - 2019Partners:Roth & Rau - Ortner GmbH, IMMS GMBH, Okmetic, SMT DD, Technikon (Austria) +10 partnersRoth & Rau - Ortner GmbH,IMMS GMBH,Okmetic,SMT DD,Technikon (Austria),KPS Ltd.,X-FAB Dresden,HEIMANN SENSOR GMBH,EDC,AMS SENSORS GERMANY,Fabmatics (Germany),FHG,SYSTEMA,MENARINI SILICON BIOSYSTEMS SPA,SenseAir (Sweden)Funder: European Commission Project Code: 661796Overall Budget: 38,905,200 EURFunder Contribution: 11,096,400 EURThe “Advanced Distributed Pilot Line for More-than-Moore Technologies” project (ADMONT) is focused on a powerful and versatile More-than-Moore (MtM) pilot line for Europe increasing the diversification of CMOS process technologies. The combination of existing expertise, technological capabilities and the manufacturing capacity of industrial and research partners creates a whole new ecosystem within Europe’s biggest silicon technology cluster “Silicon Saxony”. The distributed pilot line utilizes various MtM platform technologies for sensor and OLED processing in combination with baseline CMOS processes in a unique way and incorporates 2.5D as well as 3D integration of silicon systems into one single production flow. The technology modules, equipment and processes are not located in one single clean room, but are distributed between partners located in Dresden. This local concentration of micro- and nanotechnology facilities has various advantages for potential customer since it enables a short production cycle time and fast delivery. Such distributed MtM pilot line is unique in Europe as well as worldwide and will be implemented as “one-stop-shop” for partners and customer. It is supported by advanced design technologies to address the challenges of modelling and simulation of MtM relevant aspects like reliability, degradation effects, process variability, and IT solution aspects for MtM smart fabrication, fab automation and data processing to generate a smart infrastructure. The distributed pilot line is working as an open platform and is able to integrate future technologies for autonomous and smart system solutions. ADMONT is focused on four main key applications: smart energy, smart mobility, smart health, and smart production and essential capabilities like semiconductor process equipment and materials, design technology and smart system integration. The project consortium is organized and working along the value chain for ECS technologies in Europe.
more_vert